Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2012
02/28/2012US8124336 Methods and compositions for reducing the complexity of a nucleic acid sample
02/28/2012US8124335 Compositions and assays to detect influenza virus A and B nucleic acids
02/28/2012US8124334 Selective detection of oncogenic HPV
02/28/2012US8124333 Methods for covalent linking of optical reporters
02/28/2012US8124331 In vitro method to detect bladder transitional cell carcinoma
02/28/2012US8124330 Screening methods for cognitive enhancers
02/28/2012US8124218 Microfabricated elastomeric valve and pump systems
02/28/2012US8124110 Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species
02/28/2012US8124052 for drug screening antitumor angents; genetic engineering; microarrays; kits
02/28/2012US8124028 Automated liquid handling device and associated assay unit
02/28/2012US8123929 Small volume in vitro analyte sensor
02/28/2012US8123920 Method and apparatus for assay of electrochemical properties
02/28/2012CA2633281C Novel mutations relating to x-linked charcot-marie-tooth disease
02/28/2012CA2485506C A method for in vitro molecular evolution of protein function
02/28/2012CA2397067C Cell isolation method
02/28/2012CA2371222C Functionalised solid support for alpha-oxoaldehyde synthesis
02/28/2012CA2339901C Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences
02/23/2012WO2012024693A1 Density-based separation of biological analytes using multiphase systems
02/23/2012WO2012024691A1 Multiphase systems for analysis of solid materials
02/23/2012WO2012024690A1 Multiphase systems having multiple phase properties
02/23/2012WO2012024688A1 Multiphase systems and uses thereof
02/23/2012WO2012024642A1 Quantitative real-time pcr assay using fret dual-labeled primers
02/23/2012WO2012024639A1 Polymerase assay with a fret substrate
02/23/2012WO2012024638A2 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
02/23/2012WO2012024574A2 Small molecule arrays and methods for making and using them
02/23/2012WO2012024535A2 Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)
02/23/2012WO2012024518A1 Molecular detection of xmrv infection
02/23/2012WO2012024513A2 Molecular detection of xmrv infection
02/23/2012WO2012024439A2 Method and apparatus for electrocatalytic amplification on pre-oxidized measuring electrode
02/23/2012WO2012024302A2 Biomarkers of cancer
02/23/2012WO2012024189A2 Compositions and methods for determining predisposition to developing metabolic syndrome
02/23/2012WO2012023845A1 Methods and means for characterizing antibiotic resistance in microorganisms
02/23/2012WO2012023675A1 Modified nucleotides and real-time polymerase reaction using same
02/23/2012WO2012023648A1 Diagnostic composition for non-small-cell lung cancer comprising a preparation for measuring the hoxa11 gene methylation level, and a diagnostic method for non-small-cell lung cancer using the same
02/23/2012WO2012023622A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention
02/23/2012WO2012023583A1 Flavin enzyme having flavonol 8-hydroxylase activity and use thereof
02/23/2012WO2012023345A1 Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom
02/23/2012WO2012023298A1 Method for collection of nucleated red blood cells by density-gradient centrifugation utilizing change in density of blood cells
02/23/2012WO2012023290A1 Rasef as tumor marker and therapeutic target for cancer
02/23/2012WO2012023286A1 Lrrc42 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023285A1 Ehmt2 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023259A1 C6orf167 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023054A2 Ndm-1 polymerase chain reaction (pcr) assay
02/23/2012WO2012023020A1 Diagnostic assays for the detection and identification of aspergilli
02/23/2012WO2012022821A1 Method for obtaining an individual's genetic profile
02/23/2012WO2012022777A1 Induced sporulation screening method
02/23/2012WO2012022755A1 Helicase dependent isothermal amplification using nicking enzymes
02/23/2012WO2012022634A1 Classification, diagnosis and prognosis of multiple myeloma
02/23/2012WO2012022557A1 Reference sample for quality control in molecular diagnosis
02/23/2012WO2012022428A1 Method for isolating urea while removing objectionable co2
02/23/2012WO2012022285A2 Process for detecting l-pk tumour markers in the faeces for identifying liver diseases
02/23/2012WO2012022243A1 Kit for quantitatively detecting her2 amplification
02/23/2012WO2012021969A1 Markers of the male urogenital tract
02/23/2012WO2012003412A3 Inducible nucleic acid targets for detection of pathogens, methods and compositions thereof
02/23/2012WO2011161436A3 Prevention of proteomic and genomic damage by dicarbonyl substrates of glo 1
02/23/2012WO2011154579A4 In vitro diagnostic method for patients with splenic marginal zone lymphoma
02/23/2012WO2011140182A3 Optimized degenerative muscle disease diagnostics and treatments
02/23/2012WO2011139806A3 Integrated methods and systems for processing a molecular profile
02/23/2012WO2011133811A3 Compositions, methods and kits to detect herpes simplex virus nucleic acid
02/23/2012WO2011133599A3 Physiological methods for isolation of high purity cell populations
02/23/2012WO2011133432A3 Methods to detect and isolate cancer stem cells
02/23/2012WO2011128646A3 Genetic markers for paget's disease
02/23/2012WO2011127386A3 Improved thermal uniformity for thermal cycler instrumentation using dynamic control
02/23/2012WO2011127170A3 Methods for diagnosing and treating asthma
02/23/2012WO2011126768A3 Methods and materials for detecting colorectal cancer and adenoma
02/23/2012WO2011120048A3 Nanomotors and motion-based detection of biomolecular interactions
02/23/2012WO2011119994A3 Devices, systems, and methods for amplifying nucleic acids
02/23/2012WO2011119983A3 Biochemical oxygen demand automatic measurement device
02/23/2012WO2011119934A3 Methods and materials for detecting colorectal neoplasm
02/23/2012WO2011119771A3 Methods and compositions for detecting protein modifications
02/23/2012WO2011116276A3 Engineering correctly folded antibodies using inner membrane display of twin-arginine translocation intermediates
02/23/2012WO2011115993A3 Method for determining substance non-toxicity
02/23/2012WO2011115465A3 Method and kit for detection of pathogen of female genital organs using multiplex liquid array system
02/23/2012WO2011113047A3 Compositions and methods for characterizing breast cancer
02/23/2012WO2011112901A3 Hypermethylation biomarkers for detection of cervical cancer
02/23/2012WO2011112634A3 Molecular indicia of cellular constituents and resolving the same by super-resolution technologies in single cells
02/23/2012WO2011106314A3 Method of making nucleic acid libraries
02/23/2012WO2011096782A3 Liquid flow apparatus, fixed quantity liquid supply apparatus, and target substance extracting apparatus and target substance extracting method using the two apparatuses
02/23/2012WO2011090875A3 Primers, sequences and recombinant probes for identification of mycobacterium species
02/23/2012WO2011082198A3 Cancer biomarkers to predict recurrence and metastatic potential
02/23/2012WO2011039734A3 Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer
02/23/2012WO2011015326A8 Fructosyl amino acid oxidase
02/23/2012WO2003099989A3 Compositions and methods relating to breast specific genes and proteins
02/23/2012WO2003008563A3 Improved cytochrome p450 oxygenases
02/23/2012US20120047602 RNA-Mediated Induction of Gene Expression in Plants
02/23/2012US20120046642 Optical detector for use in therapy
02/23/2012US20120046639 Microfluidic free interface diffusion techniques
02/23/2012US20120046341 Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
02/23/2012US20120046339 Novel chorismate mutase gene from the potato cyst nematode globodera rostochiensis
02/23/2012US20120046236 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
02/23/2012US20120046233 Mutations in the lnk gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies
02/23/2012US20120046199 Method for determining the estrogen receptor status of breast cancer
02/23/2012US20120046196 ADRB2 Cancer Markers
02/23/2012US20120046195 Detecting bcl-b expression in cancer and uses thereof
02/23/2012US20120046194 METHOD FOR DIAGNOSING ACUTE LYMPHOMIC LEUKEMIA (ALL) USING MIR-146a
02/23/2012US20120046193 Method for diagnosing acute lymphomic leukemia (all) using mir-222
02/23/2012US20120046192 Method for diagnosing acute lymphomic leukemia (all) using mir-221
02/23/2012US20120046190 Hp1alpha as a prognostic marker in human cancer
02/23/2012US20120046186 Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs
02/23/2012US20120046183 method of diagnosing a mental state
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 3003